ArticleAlzheimer's research & therapy2022

Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models.

Hee Yang Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.